BIOLIFE SOLUTIONS INC Income Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Operations

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue
Product revenue
Service Revenue
Service revenue
Rental revenue
Total revenue

Cost of revenue
Gross profit
Operating expenses:
Cost of revenue (exclusive of intangible assets amortization)
Product revenue
Service Revenue
Service revenue
Rental revenue

General and administrative
Sales and marketing
Research and development
Asset impairment charges
IPR&D expense
Intangible asset amortization
Acquisition costs
Change in fair value of contingent consideration
Total operating expenses
Operating loss
Other income (expense):
Change in fair value of warrant liability
Interest income (expense), net
Other income
Loss from equity-method investment in SAVSU
Change in fair value of investments
Gain on settlement of Global Cooling escrow
Gain on acquisition of Sexton Biotechnologies, Inc.
Sexton Biotechnologies, Inc.
Total gain on acquisition of Sexton Biotechnologies, Inc.

Total other income (expense), net

Loss from continuing operations before income tax expense (benefit)
Income tax expense (benefit)
Loss from continuing operations
Discontinued operations:
Income (loss) from discontinued operations before income tax expense
Income tax expense
Income (loss) from discontinued operations
Net loss
Net loss attributable to common shareholders, basic
Loss per share - Basic:
Continuing operations (in dollars per share)
Discontinuing operations (in dollars per share)
Net loss (in dollars per share)
Loss per share - Diluted:
Continuing operations (in dollars per share)
Discontinuing operations (in dollars per share)
Net loss (in dollars per share)
Weighted average shares used to compute net loss per share attributable to common shareholders:
Basic and Diluted (in shares)
Basic (in shares)
Diluted (in shares)

Comments